Cargando…
Induction of immunogenic cell death of tumors by newly synthesized heterocyclic quinone derivative
Many cancer types are serious diseases causing mortality, and new therapeutics with improved efficacy and safety are required. Immuno-(cell)-therapy is considered as one of the promising therapeutic strategies for curing intractable cancer. In this study, we tested R2016, a newly developed heterocyc...
Autores principales: | Son, Keum-joo, Choi, Ki ryung, Ryu, Chung-Kyu, Lee, Seog Jae, Kim, Ho Jeong, Lee, Hyunah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345761/ https://www.ncbi.nlm.nih.gov/pubmed/28282460 http://dx.doi.org/10.1371/journal.pone.0173121 |
Ejemplares similares
-
Immunogenic Cell Death Induced by Ginsenoside Rg3: Significance in Dendritic Cell-based Anti-tumor Immunotherapy
por: Son, Keum-joo, et al.
Publicado: (2016) -
Cellular Mechanism of Newly Synthesized Indoledione Derivative-induced Immunological Death of Tumor Cell
por: Oh, Su-Jin, et al.
Publicado: (2011) -
Correlation between Cytotoxic Activities and Reduction Potentials of Heterocyclic Quinones
por: Koyama, Junko, et al.
Publicado: (2010) -
Biological Screening of Newly Synthesized BIAN N-Heterocyclic Gold Carbene Complexes in Zebrafish Embryos
por: Farooq, Muhammad, et al.
Publicado: (2015) -
Cytotoxic Effects of Newly Synthesized Heterocyclic Candidates Containing Nicotinonitrile and Pyrazole Moieties on Hepatocellular and Cervical Carcinomas
por: A. El-Sayed, Amira, et al.
Publicado: (2019)